Encompass Health Corp.
Income Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $5.94B | $5.37B | $4.80B | $4.35B | $4.01B | $3.57B | $4.61B | $4.28B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — | — | — |
| Operating Expenses | ||||||||
| Research & Development | — | — | — | — | — | — | — | — |
| SG&A Expense | $236.2M | $209.2M | $201.7M | $154.3M | $169.5M | $151.6M | $247.0M | $220.2M |
| Operating Income | $953.0M | $749.6M | $750.7M | $539.5M | $559.6M | $563.9M | $612.1M | $555.2M |
| Operating Margin | 16.1% | 14.0% | 15.6% | 12.4% | 13.9% | 15.8% | 13.3% | 13.0% |
| Interest Expense | — | — | $143.5M | $175.7M | $164.3M | $183.7M | $159.7M | $147.3M |
| Pretax Income | $953.0M | $749.6M | $607.2M | $450.8M | $505.0M | $352.9M | $562.3M | $493.2M |
| Income Tax Expense | $192.9M | $150.2M | $132.2M | $100.1M | $101.9M | $74.7M | $115.9M | $118.9M |
| Net Income | $566.2M | $455.7M | $352.0M | $271.0M | $412.2M | $284.2M | $358.7M | $292.3M |
| Net Margin | 9.5% | 8.5% | 7.3% | 6.2% | 10.3% | 8.0% | 7.8% | 6.8% |
| EPS (Basic) | $5.62 | $4.53 | $3.51 | $2.72 | $4.15 | $2.87 | $3.65 | $2.98 |
| EPS (Diluted) | $5.54 | $4.46 | $3.47 | $2.70 | $4.11 | $2.85 | $3.61 | $2.93 |
| Shares Outstanding (Basic) | 100.5M | 99.9M | 99.5M | 99.2M | 99.0M | 98.6M | 98.0M | 97.9M |
| Shares Outstanding (Diluted) | 102.2M | 102.2M | 101.3M | 100.4M | 100.2M | 99.8M | 99.4M | 99.8M |
| Dividends Per Share | $0.72 | $0.64 | $0.60 | $0.86 | $1.12 | $1.12 | $1.10 | $1.04 |